Sartorius AG (Sartorius AG) Total Stockholders Equity : $2,904 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Sartorius AG Total Stockholders Equity?

Sartorius AG's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $2,904 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Sartorius AG's Book Value per Share for the quarter that ended in Mar. 2024 was $42.44. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Sartorius AG's Debt-to-Equity for the quarter that ended in Mar. 2024 was 1.95.

Sartorius AG Total Stockholders Equity Historical Data

The historical data trend for Sartorius AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Total Stockholders Equity Chart

Sartorius AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

900.39

1,254.79

1,424.07

2,107.84

2,254.42

Sartorius AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															2,063.28	2,206.72	2,206.19	2,254.42	2,903.80

Sartorius AG (OTCPK:SARTF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Sartorius AG's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2903.804	-	0)	/	68.422
	=	42.44

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Sartorius AG's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(365.761	+	5285.87)	/	2903.804
	=	1.95

Sartorius AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius AG (Sartorius AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (OTCPK:SARTF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

SOAGY:USA SSSGY:USA SUVPF:USA 1SRT3:Italy SRT3d:UK 0NIR:UK SRT3:Germany SRT3:Austria

Address

Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079

Website

https://www.sartorius.com

Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.